A Two-in-One antibody engineered from a humanized interleukin 4 antibody through mutation in heavy chain complementarity-determining regions

References

• Dhimolea E, Reichert JM. World Bispecific Antibody Summit, September 27-28, 2011, Boston, MA. MAbs 2012; 4:4 - 13; http://dx.doi.org/10.4161/mabs.4.1.18821; PMID: 22327426
   PubMedGoogle Scholar
• Kontermann R. Dual targeting strategies with bispecific antibodies. MAbs 2012; 4:182 - 97; http://dx.doi.org/10.4161/mabs.4.2.19000; PMID: 22453100
   PubMed Web of Science ®Google Scholar
• Eigenbrot C, Fuh G. Two-in-One antibodies with dual action Fabs. Curr Opin Chem Biol 2013; 17:400 - 5; http://dx.doi.org/10.1016/j.cbpa.2013.04.015; PMID: 23683347
   PubMed Web of Science ®Google Scholar
• Koenig P, Fuh G. Two-in-One antibodies. In: Kontermann R, ed. Bispecific antibodies: Springer, 2011:187-98.
   Google Scholar
• Bostrom J, Yu SF, Kan D, Appleton BA, Lee CV, Billeci K, Man W, Peale F, Ross S, Wiesmann C, et al. Variants of the antibody herceptin that interact with HER2 and VEGF at the antigen binding site. Science 2009; 323:1610 - 4; http://dx.doi.org/10.1126/science.1165480; PMID: 19299620
   PubMed Web of Science ®Google Scholar
• Bostrom J, Haber L, Koenig P, Kelley RF, Fuh G. High affinity antigen recognition of the dual specific variants of herceptin is entropy-driven in spite of structural plasticity. PLoS One 2011; 6:e17887; http://dx.doi.org/10.1371/journal.pone.0017887; PMID: 21526167
   PubMed Web of Science ®Google Scholar
• Schaefer G, Haber L, Crocker LM, Shia S, Shao L, Dowbenko D, Totpal K, Wong A, Lee CV, Stawicki S, et al. A two-in-one antibody against HER3 and EGFR has superior inhibitory activity compared with monospecific antibodies. Cancer Cell 2011; 20:472 - 86; http://dx.doi.org/10.1016/j.ccr.2011.09.003; PMID: 22014573
   PubMed Web of Science ®Google Scholar
• Colby DW, Garg P, Holden T, Chao G, Webster JM, Messer A, Ingram VM, Wittrup KD. Development of a human light chain variable domain (V(L)) intracellular antibody specific for the amino terminus of huntingtin via yeast surface display. J Mol Biol 2004; 342:901 - 12; http://dx.doi.org/10.1016/j.jmb.2004.07.054; PMID: 15342245
   PubMed Web of Science ®Google Scholar
• Spiess C, Bevers J 3rd, Jackman J, Chiang N, Nakamura G, Dillon M, Liu H, Molina P, Elliott JM, Shatz W, et al. Development of a human IgG4 bispecific antibody for dual targeting of interleukin-4 (IL-4) and interleukin-13 (IL-13) cytokines. J Biol Chem 2013; 288:26583 - 93; http://dx.doi.org/10.1074/jbc.M113.480483; PMID: 23880771
   PubMed Web of Science ®Google Scholar
• Lee CV, Sidhu SS, Fuh G. Bivalent antibody phage display mimics natural immunoglobulin. J Immunol Methods 2004; 284:119 - 32; http://dx.doi.org/10.1016/j.jim.2003.11.001; PMID: 14736422
   PubMed Web of Science ®Google Scholar
• Sidhu SS, Li B, Chen Y, Fellouse FA, Eigenbrot C, Fuh G. Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions. J Mol Biol 2004; 338:299 - 310; http://dx.doi.org/10.1016/j.jmb.2004.02.050; PMID: 15066433
   PubMed Web of Science ®Google Scholar
• Lee CV, Liang WC, Dennis MS, Eigenbrot C, Sidhu SS, Fuh G. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold. J Mol Biol 2004; 340:1073 - 93; http://dx.doi.org/10.1016/j.jmb.2004.05.051; PMID: 15236968
   PubMed Web of Science ®Google Scholar
• LaPorte SL, Juo ZS, Vaclavikova J, Colf LA, Qi X, Heller NM, Keegan AD, Garcia KC. Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system. Cell 2008; 132:259 - 72; http://dx.doi.org/10.1016/j.cell.2007.12.030; PMID: 18243101
   PubMed Web of Science ®Google Scholar
• Milburn MV, Hassell AM, Lambert MH, Jordan SR, Proudfoot AE, Graber P, Wells TN. A novel dimer configuration revealed by the crystal structure at 2.4 A resolution of human interleukin-5. Nature 1993; 363:172 - 6; http://dx.doi.org/10.1038/363172a0; PMID: 8483502
   PubMed Web of Science ®Google Scholar
• Patino E, Kotzsch A, Saremba S, Nickel J, Schmitz W, Sebald W, Mueller TD. Structure analysis of the IL-5 ligand-receptor complex reveals a wrench-like architecture for IL-5Rα. Structure 2011; 19:1864 - 75; http://dx.doi.org/10.1016/j.str.2011.08.015; PMID: 22153509
   PubMed Web of Science ®Google Scholar
• Finkelman FD, Hogan SP, Hershey GK, Rothenberg ME, Wills-Karp M. Importance of cytokines in murine allergic airway disease and human asthma. J Immunol 2010; 184:1663 - 74; http://dx.doi.org/10.4049/jimmunol.0902185; PMID: 20130218
   PubMed Web of Science ®Google Scholar
• Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, Marshall RP, Bradding P, Green RH, Wardlaw AJ, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009; 360:973 - 84; http://dx.doi.org/10.1056/NEJMoa0808991; PMID: 19264686
   PubMed Web of Science ®Google Scholar
• Hötzel I, Theil FP, Bernstein LJ, Prabhu S, Deng R, Quintana L, Lutman J, Sibia R, Chan P, Bumbaca D, et al. A strategy for risk mitigation of antibodies with fast clearance. MAbs 2012; 4:753 - 60; http://dx.doi.org/10.4161/mabs.22189; PMID: 23778268
   PubMed Web of Science ®Google Scholar
• Bostrom J, Lee CV, Haber L, Fuh G. Improving antibody binding affinity and specificity for therapeutic development. Methods Mol Biol 2009; 525:353 - 76, xiii; http://dx.doi.org/10.1007/978-1-59745-554-1_19; PMID: 19252851
   PubMedGoogle Scholar
• Lee CV, Hymowitz SG, Wallweber HJ, Gordon NC, Billeci KL, Tsai SP, Compaan DM, Yin J, Gong Q, Kelley RF, et al. Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cells. Blood 2006; 108:3103 - 11; http://dx.doi.org/10.1182/blood-2006-03-011031; PMID: 16840730
   PubMed Web of Science ®Google Scholar
• Foote J, Winter G. Antibody framework residues affecting the conformation of the hypervariable loops. J Mol Biol 1992; 224:487 - 99; http://dx.doi.org/10.1016/0022-2836(92)91010-M; PMID: 1560463
   PubMed Web of Science ®Google Scholar
• Kelley RF, O’Connell MP. Thermodynamic analysis of an antibody functional epitope. Biochemistry 1993; 32:6828 - 35; http://dx.doi.org/10.1021/bi00078a005; PMID: 7687461
   PubMed Web of Science ®Google Scholar
• Cunningham BC, Jhurani P, Ng P, Wells JA. Receptor and antibody epitopes in human growth hormone identified by homolog-scanning mutagenesis. Science 1989; 243:1330 - 6; http://dx.doi.org/10.1126/science.2466339; PMID: 2466339
   PubMed Web of Science ®Google Scholar
• Vajdos FF, Adams CW, Breece TN, Presta LG, de Vos AM, Sidhu SS. Comprehensive functional maps of the antigen-binding site of an anti-ErbB2 antibody obtained with shotgun scanning mutagenesis. J Mol Biol 2002; 320:415 - 28; http://dx.doi.org/10.1016/S0022-2836(02)00264-4; PMID: 12079396
   PubMed Web of Science ®Google Scholar
• Kunkel TA, Roberts JD, Zakour RA. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol 1987; 154:367 - 82; http://dx.doi.org/10.1016/0076-6879(87)54085-X; PMID: 3323813
   PubMed Web of Science ®Google Scholar
• Koenig P, Fuh G. Selection and screening using antibody phage display libraries. Methods Mol Biol 2014; 1131:133 - 49; http://dx.doi.org/10.1007/978-1-62703-992-5_9; PMID: 24515464
   PubMedGoogle Scholar